Valink Therapeutics

formerly Valink

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Boston, United States · Founded 2021 · $11.8M raised

Employees
11–50
Founded
2021
Total Funding
$11.8M
Last Round
$11.8M Pre-SeedOct 2025
Rounds
1

About

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

Summary

Valink Therapeutics is a Biotech company based in Boston, United States, founded in 2021. It has raised $11.8M in total across 1 round, most recently a $11.8M Pre-Seed round in Oct 2025. Investors include LongeVC, Oxford Science Enterprises and Redalpine.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-AOct 2025
$11.8M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Valink Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/valinktx"><img src="https://indexed.vc/api/badge/company/valinktx" alt="Valink Therapeutics on Indexed.vc" width="260" height="76" /></a>